Back to the articles list | Back to browse issues page

XML Print

Diagnostic Value of Polarized Light Microscopy in Pseudogout: A Review of Calcium Pyrophosphate Deposition Disease in the Clinical Laboratory
Mohammadreza Sheikh Sajjadieh
Member of Australian Institute of Medical and clinical Scientist, Melborn, Australia , mohammad_esfahan@yahoo.com
Abstract:   (63 Views)
Pseudogout, or calcium pyrophosphate deposition disease, is a common but frequently underdiagnosed form of crystal-induced arthritis. It is characterized by the deposition of calcium pyrophosphate dihydrate crystals in joint cartilage and synovial fluid. Although the clinical presentation often mimics gout or septic arthritis, the underlying pathophysiology and crystal morphology differ significantly. This review highlights the crucial role of polarized light microscopy in the diagnosis of Pseudogout, particularly in differentiating it from other forms of arthritis. Polarized Light Microscopy is a valuable diagnostic tool that allows for the visualization and identification of rhomboid-shaped, weakly positively birefringent crystals. I discuss the principles of Polarized Light Microscopy, specimen handling, morphological features of crystals, and current laboratory practices, as well as the importance of technician training in enhancing diagnostic accuracy. By raising awareness and encouraging the standardized use of Polarized Light Microscopy, we aim to improve the detection and management of pseudogout in clinical laboratory settings.
V
Keywords: pseudogout, calcium pyrophosphate deposition disease, polarized light microscopy, crystal arthritis, synovial fluid, birefringence, chondrocalcinosis
Full-Text [PDF 367 kb]   (31 Downloads)    
Research Article: Review Article | Subject: Laboratory Sciences
Received: 2025/05/13 | Accepted: 2025/12/18
References
1. Zhang W, Doherty M, Pascual E, Barskova V, Guerne P-A, Jansen TL, et al. EULAR recommendations for calcium pyrophosphate deposition. Part II: management. Ann Rheum Dis. 2011;70(4):571-5. [View at Publisher] [DOI] [PMID] [Google Scholar]
2. Rosales-Alexander JL, Balsalobre Aznar J, Magro-Checa C. Calcium pyrophosphate crystal deposition disease: diagnosis and treatment. Open Access Rheumatol. 2014;6:39-47. [View at Publisher] [DOI] [PMID] [Google Scholar]
3. Abhishek A, Doherty M. Pathophysiology of articular chondrocalcinosis-role of ANKH. Nat Rev Rheumatol. 2011;7(2):96-104. [View at Publisher] [DOI] [PMID] [Google Scholar]
4. Martinon F, Pétrilli V, Mayor A, Tardivel A, Tschopp J. Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature. 2006;440(7081):237-41. [View at Publisher] [DOI] [PMID] [Google Scholar]
5. Pascual E, Sivera F, Andrés M. Synovial fluid analysis for crystals. Curr Opin Rheumatol. 2011;23(2):161-9. [View at Publisher] [DOI] [PMID] [Google Scholar]
6. Verbruggen G, Wittoek R, Vander Cruyssen B, Elewaut D. Tumour necrosis factor blockade for the treatment of erosive osteoarthritis of the interphalangeal finger joints: a double blind, randomised trial on structure modification. Ann Rheum Dis. 2012;71(6):891-8. [View at Publisher] [DOI] [PMID] [Google Scholar]
7. McGill NW. Practical crystal identification in the laboratory. Aust Fam Physician. 2013;42(4):198-201.
8. Ryan LM, McCarty DJ. Calcium pyrophosphate crystal deposition disease: pseudogout and articular chondrocalcinosis. In: Firestein GS, Budd RC, Gabriel SE, McInnes IB, O'Dell JR, editors. Kelley & Firestein’s. Textbook of Rheumatology. 10th ed. Philadelphia: Elsevier; 2017. [View at Publisher]
9. Gatter RA, Schumacher HR. Hypomagnesemia and calcium pyrophosphate deposition disease. Arch Intern Med. 1982;142(9):1659-60.
10. Rosentha AK, Ryan LM. Clinical practice. Calcium pyrophosphate deposition disease. N Engl J Med. 2016;374(26):2575–84. [View at Publisher] [DOI] [PMID] [Google Scholar]
11. Schumacher HR. Crystal-induced arthritis: an overview. Am J Med. 1996;100(2A):46S-52S. [View at Publisher] [DOI] [PMID] [Google Scholar]
12. Sheikh Sajjadieh M, Ajami A, Haghshenas L. Estimation of sensitivity and specificity of antinuclear antibody by automated indirect immunofluorescence and enzyme-linked immunoassay. mljgoums. 2024;18(4):22-3. [View at Publisher] [DOI] [Google Scholar]
Add your comments about this article : Your username or Email:
CAPTCHA
Send email to the article author

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.